{
  "pdfPath": "/home/arkantu/Documentos/Zotero Biblioteca/Neurología/Clinical practice/Clinical Reasoning/Ritter et al. - 2013 - Clinical Reasoning Rapidly progressive quadriparesis in a forgetful patient.pdf",
  "fileName": "Ritter et al. - 2013 - Clinical Reasoning Rapidly progressive quadriparesis in a forgetful patient.pdf",
  "relativePath": "Neurología/Clinical practice/Clinical Reasoning/Ritter et al. - 2013 - Clinical Reasoning Rapidly progressive quadriparesis in a forgetful patient.pdf",
  "text": "RESIDENT\n              & FELLOW\n              SECTION\n                              Clinical Reasoning:\nSection Editor                Rapidly progressive quadriparesis in a\nMitchell S.V. Elkind,\nMD, MS                        forgetful patient\n\nLaura Mantoan Ritter,         SECTION 1\n                                                                                                                    Figure          MRI brain (fluid-attenuated inversion\n   MD, PhD, MRCP              A 50-year-old right-handed retired family business                                                    recovery sequence) shows high signal in\nJeremy D. Isaacs, PhD,        manager developed progressive left-sided weakness over                                                the corticospinal tract (small arrows)\n   MRCP                       5 days after a mechanical fall. She remembered catching\nMeriel McEntagart, MD         her foot on the carpet and falling down a flight of stairs,\nJohn P. O’Dwyer, MA,          followed by severe neck pain over C4-C5 and inability\n   MD, MRCPI                  to get up for nearly an hour. Over the subsequent\n                              month her symptoms progressed and she presented to\n                              the hospital with an asymmetric spastic paraparesis, loss\nCorrespondence to             of pinprick sensation in her arms and legs, loss of vibra-\nDr. Mantoan Ritter:\nlauramantoan@doctors.org.uk\n                              tion sense to both hips, and double incontinence.\n                                  MRI of the patient’s cervical spine revealed severe\n                              cervical canal stenosis but no cord abnormality, while\n                              brain MRI showed high signal in the corticospinal tract\n                              bilaterally (figure). Somatosensory evoked potentials\n                              (SSEPs) were of low amplitude but not delayed. The\n                              patient stabilized on a rehabilitation ward and was dis-\n                              charged home independent and continent but with\n                              some frequency of micturition.\n                                  When reviewed in clinic 2 months later, the patient\n                              had significantly deteriorated, was wheelchair-bound,                              Although not formally measured, there was relevant sulcal\n                              and complained of memory deterioration, slurred speech,                            enlargement, including a wide sylvian fissure (thick arrow) and\n                              coughing on free fluids, and new right-sided weakness.                             widening of the right central sulcus at the lateral aspect\n                                                                                                                 (sequence not shown), suggestive of frontotemporal atrophy.\n                                  The patient’s medical history included unex-\n                              plained collapses with a postictal confusional period                              housework and was unable to reason in a 2-step strat-\n                              of 30 minutes since age 14 years. Her mother died of                               egy (such as making decisions about her own care). She\n                              dementia at age 68 and her brother of a stroke at age                              was concrete in her ways and did not want any change.\n                              50. She was an ex-smoker of 20 cigarettes per day and                              She had dysarthria with mild nasal escape and a spastic\n                              rarely consumed alcohol.                                                           quadriparesis with pyramidal weakness (worse on the\n                                  On cognitive assessment using the Addenbrooke’s                                left and in her upper limbs), sustained ankle clonus,\n                              Cognitive Assessment–Revised, the patient scored 67/                               and hyperreflexia. Sensory examination was normal.\n                              100, losing points for attention; poor category and\n                                                                                                                 Questions for consideration:\n                              letter fluency; memory, naming, and abstract reason-\n                              ing; writing; and constructional ability. She also had                             1. What is the differential diagnosis in a patient with\n                              behavioral changes: she was disinhibited and emotion-                                 pyramidal weakness and cognitive problems?\n                              ally labile (pseudobulbar affect with pathologic smiling                           2. In view of her imaging results and abnormal SSEP,\n                              and laughter). She had become disorganized with                                       what tests should one consider?\n\n\n\n\n                                                                                                                                                                 GO TO SECTION 2\n\n\n\n\n                              From the Neurology Department (L.M.R., J.D.I., J.P.O.) and Medical Genetics Department (M.M.), St George’s NHS Healthcare Trust, London, UK.\n                              Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.\n\ne154                          © 2013 American Academy of Neurology\n\n   ª 2013 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                               SECTION 2                                                              cytoplasmic antibodies, immunoglobulins, and serum\n                               In a patient with chronic progressive motor symptoms                   protein electrophoresis, were normal or negative.\n                               and cognitive problems, the differential diagnosis                         CSF analysis revealed a normal cell count, normal\n                               includes inflammatory, infectious (e.g., HIV, Lyme                     cellularity, and no growth after 48 hours incubation,\n                               disease, Whipple disease, neurosyphilis, and non-                      ruling out an active inflammatory process. CSF glu-\n                               tuberculous mycobacterial infection), metabolic/toxic,                 cose and the CSF glucose/serum glucose ratio were\n                               neurodegenerative, and paraneoplastic causes (table).                  normal. Oligoclonal bands were negative and CSF\n                               An initial screen should include a full blood count with               protein was marginally elevated at 0.71 g/L.\n                               differential, urea and electrolytes (including corrected                   A paraneoplastic syndrome was also considered.\n                               calcium and phosphate concentrations), liver function                  CT of thorax, abdomen, and pelvis only showed a\n                               tests, amylase, and C-reactive protein, which were nor-                few calcified nodules within both hemithoraces, consis-\n                               mal in our patient. Normal thyroid function tests and                  tent with previous granulomatous infection. Bilateral\n                               vitamin B12 levels ruled out hypothyroidism and B12                    mammograms were unremarkable. In view of the rapid\n                               deficiency as a metabolic cause of her symptoms.                       progression of the patient’s symptoms, an MRI of her\n                               She had a slightly low folate level of 3.0 mg/L (normal                brain was repeated with gadolinium administration,\n                               range 5–10 mg/L). Ferritin, lead, cadmium, and                         showing once again the high signal in the corticospinal\n                               thallium levels were measured to exclude toxic                         tracts and asymmetrical bilateral frontotemporal atro-\n                               causes of encephalopathy and motor symptoms                            phy (figure). She declined a body PET-CT.\n                               and were normal. Serologic investigations for                              In view of the patient’s previous history suggesting\n                               inflammatory diseases, including serum angiotensin-                    seizures and to ensure her cognitive problems were not\n                               converting enzyme, rheumatoid factor, antineutrophil                   due to underlying ictal phenomena, an EEG was\n\n\n\n\nTable       Differential diagnosis for progressive pyramidal weakness and cognitive problems\n\nDifferential diagnosis                     Clinical characteristics                                        Diagnostic tests\n\nNeurodegenerative diseases\n\n  Amyotrophic lateral sclerosis (ALS)      Combination of upper and lower motor neuron signs               EMG shows denervation. NCS show normal motor and\n  with frontotemporal dementia             (fasciculations) plus frontotemporal cognitive deficits         sensory conduction (no conduction block). MRI: high\n                                                                                                           signal in corticospinal tracts and frontotemporal atrophy\n                                                                                                           (but mainly used to rule out other causes). SSEPs: loss of\n                                                                                                           or low amplitude. Neuropsychology suggestive of\n                                                                                                           frontotemporal deficits.\n\n  Alzheimer disease (AD) with              Autosomal dominantly inherited syndrome of AD-type              Neuropsychometric testing shows focal or lateralized\n  presenilin-1 (PSEN1) mutation            dementia; onset in early 50s is typical; associated with        cognitive deficits with early involvement of memory and\n                                           heterogeneous neurologic symptoms including spastic             learning. CT/MRI: generalized or focal atrophy. PET/\n                                           paraparesis (which is a strong indicator for PSEN1              SPECT: hypoperfusion/low metabolism in hippocampus,\n                                           mutation), seizures, and myoclonus                              precuneus, and parietotemporal cortex (AD). Genetic\n                                                                                                           testing for PSEN1 mutation.\n\n  Corticobasal degeneration (CBD),         Insidious onset, cortical dysfunction with sensory              Neuropsychometric testing shows focal or lateralized\n  progressive supranuclear palsy (PSP)     disturbance (alien hand) and apraxia, extrapyramidal            cognitive deficits with sparing (CBD) of memory and\n                                           dysfunction (akinetic-rigid syndrome)                           learning. CT/MRI: focal/asymmetric atrophy (CBD),\n                                                                                                           midbrain atrophy (PSP). PET/SPECT: focal/asymmetric\n                                                                                                           hypoperfusion with sparing of basal ganglia (CBD).\n\n  Wilson disease (with neurologic          Psychiatric symptoms, dementia, rigidity, and                   Serum: ceruloplasmin level below 20 mg/dL. Urine: urinary\n  involvement)                             extrapyramidal features; Kayser-Fleischer corneal arcus         copper excretion .100 mg over 24 hours. MRI: high T2\n                                           in 50%–60% of patients; family history                          signal in basal ganglia, brainstem, white matter. Genetics:\n                                                                                                           mutation in Wilson gene ATP7B on chromosome 13.\n\n  Creutzfeldt-Jakob disease                Rapidly progressive dementia, myoclonus, ataxia,                MRI: high signal in putamen and head of caudate\n                                           pyramidal signs                                                 (sensitivity 83%–92%, specificity 87%–95%). CSF:\n                                                                                                           positive for protein 14-3-3 (can be normal in familial\n                                                                                                           forms and elevated in nonprion disease of the CNS).\n                                                                                                           EEG: periodic synchronous biphasic or triphasic sharp\n                                                                                                           wave complexes (sensitivity 67%, specificity 85%).\n\nInflammatory/autoimmune disease\n\n  Inflammation (acute disseminated         Gradual/subacute onset of sensory and motor deficit;            MRI: high T2 and FLAIR signal, new lesions enhance with\n  encephalomyelitis, MS)                   cerebellar, brainstem signs or myelopathy                       contrast. CSF: positive for unmatched oligoclonal bands in\n                                                                                                           MS (pleocytosis or increased protein common in ADEM).\n                                                                                                           Visual- and brainstem-evoked responses can be delayed.\n\nParaneoplastic disease\n\n  Paraneoplastic encephalomyelitis 6       Subacute encephalitis with confusion, behavioral and            Serum: positive anti-Ro, La, Hu, Ma2, GAD/amphiphysin,\n  anterior horn cell involvement           cognitive difficulties, brainstem signs                         or TPO antibodies, CT thorax/abdo/pelvis, PET scan,\n                                                                                                           mammogram, testicular ultrasound to identify possible\n                                                                                                           primary tumor.\n\n                                                                                                                                                         Continued\n\n\n                                                                                                     Neurology 81    November 19, 2013                            e155\n\nª 2013 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f  Table        Continued\n\n  Differential diagnosis                     Clinical characteristics                                      Diagnostic tests\n\n  Nutritional/metabolic deficiencies\n\n    Vitamin B12 deficiency                   Subacute combined degeneration of the cord, dementia,         Serum: B12 levels low.\n                                             encephalopathy, sensory polyneuropathy\n\n    Folate deficiency                        Subacute combined degeneration of the cord-like               Serum: folate levels low.\n                                             picture\n\n    Hypothyroidism                           Cognitive slowing and dementia, fatigue, constipation,        Serum: TSH high or low, fT4 and fT3 low.\n                                             cold intolerance\n\n    Adult-onset metachromatic                Autosomal recessive, presents with dementia or                Serum: deficiency of arylsulfatase A.\n    leukodystrophy                           psychiatric features, pyramidal signs, speech problems,\n                                             ataxia\n\n    Adult-onset hexosaminidase A             Autosomal recessive, variable clinical features even          Assay of hexosaminidase A enzymatic activity; if\n    deficiency                               within same family, can present with spinal muscular          decreased: molecular genetic testing for HEXA mutations.\n                                             atrophy or early-onset ALS features (wasting, weakness,\n                                             fasciculations, upper motor neuron signs), dysarthria,\n                                             and cognitive impairment\n\n    Adult polyglucosan body disease          Autosomal recessive, progressive upper and lower motor        MRI: progressive white matter changes (paraventricular,\n                                             neuron signs with gait difficulty, mild cognitive             subcortical, and as far as the craniocervical junction).\n                                             impairment, neurogenic bladder dysfunction                    NCS/EMG: lumbosacral axonal polyradiculoneuropathy.\n                                                                                                           Sural nerve biopsy: typical polyglucosans within nerve\n                                                                                                           tubes. Low glycogen branching enzyme (GBE) activity in\n                                                                                                           skin fibroblast cultures and GBE1 mutations on\n                                                                                                           molecular genetic testing.\n\n  Infectious causes\n\n    HIV                                      AIDS dementia complex in advanced disease;                    Serum: HIV serology, CD4 count, viral titer, check for\n                                             myelopathy due to IRIS or JC virus infection                  concomitant hepatitis coinfection.\n\n    Syphilis                                 Delirium and dementia; myelopathy and sensory                 Serum: VDRL/TPHA test.\n                                             neuropathy\n\n    Chronic Lyme disease                     Lyme encephalopathy or (rarely) chronic                       Serum/CSF: high titer of anti–Borrelia burgdorferi IgM or\n                                             encephalomyelitis with spastic paraparesis, cranial           IgG (ELISA followed by a Western blot) or isolation of B\n                                             neuropathies, and cognitive impairment; arthritis;            burgdorferi from clinical specimen.\n                                             acrodermatitis chronica atrophicans\n\n    Whipple disease                          Migratory arthralgia, diarrhea, abdominal pain; cognitive     Demonstration of Tropheryma whippelii on small-bowel\n                                             dysfunction, oculomasticatory myorhythmia, gaze palsy;        biopsy (periodic acid-Schiff–positive macrophages). MRI/\n                                             multiple neurologic symptoms possible                         CT may show high signal lesions in CNS disease. PCR of\n                                                                                                           CSF, brain tissue, and peripheral blood possible.\n\n  Toxic causes\n\n    Heavy metal poisoning (lead, mercury,    Acute confusion, dementia                                     Serum: lead and mercury levels.\n    cadmium, thallium)\n\nAbbreviations: ADEM 5 acute disseminated encephalomyelitis; FLAIR 5 fluid-attenuated inversion recovery; GAD 5 glutamic acid decarboxylase; Ig 5\nimmunoglobulin; IRIS 5 immune reconstitution inflammatory syndrome; MS 5 multiple sclerosis; NCS 5 nerve conduction studies; SSEP 5 somatosensory\nevoked potential; TPHA 5 Treponema pallidum hemagglutination assay; TPO 5 thyroid peroxidase; TSH 5 thyroid-stimulating hormone; VDRL 5 Venereal\nDisease Research Laboratory.\n\n\n\n                                 performed. This showed diffuse theta waves, suggestive               vital capacity of 0.9 L. Early morning arterial blood\n                                 of a mild nonspecific cerebral dysfunction. EMG                      gas analysis showed a pO2 of 9.73 kPa and a pCO2\n                                 showed evidence of widespread chronic partial dener-                 of 9.84 kPa, with a base excess of 3.4 mmol/L.\n                                 vation with active changes in all 4 limbs and respiratory\n                                 muscles. In view of the rapidly progressive course of the\n                                                                                                      Questions for consideration:\n                                 illness, the abnormalities were interpreted in keeping\n                                 with a diagnosis of motor neuron disease, possibly with              1. What is your diagnosis?\n                                 associated frontotemporal dementia.                                  2. How would you interpret the MRI findings?\n                                     By then, the patient had developed prominent fas-                3. What further tests could you consider to investi-\n                                 ciculations in upper and lower limbs and had a forced                   gate the cause of her disease?\n\n\n\n\n                                                                                                                                             GO TO SECTION 3\n\n\n\n\ne156                             Neurology 81   November 19, 2013\n\n   ª 2013 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                  SECTION 3                                                       present in 700–1,600 copies.8 While the exact patho-\n                  The combination of clinical and electrophysiologic evi-         genic mechanism is unknown, it is thought that the\n                  dence of progressive lower and upper motor neuron               high number of repeats disrupts the alternative splicing\n                  signs in 2 segments, in the absence of any other relevant       of the C9orf72 transcripts and leads to RNA accumula-\n                  disease process, fulfills the El Escorial criteria for clini-   tion in the nucleus.8 This may, in turn, lead to\n                  cally probable amyotrophic lateral sclerosis (ALS).1            dysfunction of RNA binding proteins and cellular func-\n                  Additionally, our patient had cognitive problems, which         tions. Histopathologically, both transactive response\n                  were confirmed as predominantly frontotemporal on               DNA binding protein of 43 kDa (TDP-43) and p62-\n                  formal neuropsychological assessment. The combina-              positive neuronal inclusions have been shown in the\n                  tion of these 2 clinical syndromes supported a diagnosis        cerebral and cerebellar cortex of patients with the hex-\n                  of ALS–frontotemporal dementia (ALS-FTD). Her                   anucleotide repeat expansion.9 Clinically, patients with\n                  MRI and SSEP findings strongly supported the diag-              the C9orf72 repeat expansion also have a recognizable\n                  nosis, as prominence of the corticospinal tracts on MRI         phenotype,7 comprising a family history of dementia or\n                  and low amplitude or loss of SSEPs2,3 are recognized            ALS, an earlier age at onset, evidence of cognitive\n                  features in ALS. Frontotemporal atrophy on MRI sup-             impairment, and, in many instances, a rapid disease\n                  ported the diagnosis of FTD. Another neurodegen-                progression.7\n                  erative condition that can present with spasticity and              Had the C9orf72 hexanucleotide repeats been in the\n                  dementia is corticobasal degeneration, where SSEPs are          normal range, our genetic testing strategy would have\n                  typically delayed rather than of low amplitude or lost,         been directed, in order, at testing for mutations in the\n                  as in this case. Of note, the transient sensory symptoms        TARDBP, FUS, and SOD1 gene, as mode of inheritance\n                  the patient had originally presented with and that had          and clinical presentation would fit with our patient’s,\n                  resolved were thought to be related to soft tissue injury       although for FUS and SOD1 gene mutations the clinical\n                  and her cervical stenosis.                                      presentation is usually more toward the ALS part of the\n                       As rapidly progressive ALS has occasionally been re-       spectrum and the mean age at onset tends to be earlier.\n                  ported as a paraneoplastic syndrome, we tested for the              Although the pathogenetic mechanisms are not\n                  following tumor markers and paraneoplastic antibodies,          fully understood, the C9orf72 repeat expansion may\n                  which were all reported as not significantly raised or          become a pharmacogenetic target for presymptomatic\n                  negative: carcinoma antigen (CA) 15-3; CA 19-9; CA              carriers. Further research and a recently founded online\n                  125; carcinoembryonic antigen (CEA); a-fetoprotein;             gene database10 will keep us informed on new insights\n                  antibodies against Hu, amphiphysin, Ri, and CV2.1;              into the pathogenetic mechanisms and penetrance of\n                  and neuronal and thyroid microsomal antibodies. The             this and other mutations causing familial ALS-FTD.\n                  patient tested weakly positive for Purkinje cell (Yo)\n                  antibodies on immunoblot.                                       AUTHOR CONTRIBUTIONS\n                                                                                  Laura Mantoan Ritter: drafting/revising the manuscript, study concept or\n                       In view of the patient’s family history of dementia and\n                                                                                  design, analysis or interpretation of data, accepts responsibility for conduct\n                  her presentation with combined ALS and FTD, we                  of research and final approval, acquisition of data, study supervision. Jeremy\n                  tested her for the recently described C9orf72 hexanucleo-       D. Isaacs: drafting/revising the manuscript, accepts responsibility for conduct\n                  tide mutation. This is the most common mutation iden-           of research and final approval. Meriel McEntagart: drafting/revising the man-\n                                                                                  uscript, accepts responsibility for conduct of research and final approval, acqui-\n                  tified so far in familial ALS.5 Southern blotting confirmed\n                                                                                  sition of data. John Philip O’Dwyer: drafting/revising the manuscript, study\n                  C9orf72 hexanucleotide (GGGGCC) expansion in the                concept or design, analysis or interpretation of data, accepts responsibility for\n                  pathogenic range. She died shortly after discharge home         conduct of research and final approval, acquisition of data, study supervision.\n                  on riluzole and had not consented to a postmortem.\n                                                                                  STUDY FUNDING\n                  DISCUSSION ALS is familial in 5%–10% of cases.                  No targeted funding reported.\n                  Up to 50% of patients with ALS also develop cogni-\n                  tive impairment, while 5%–15% are diagnosed with                DISCLOSURE\n                                                                                  The authors report no disclosures relevant to the manuscript. Go to\n                  dementia, most commonly of the frontotemporal type\n                                                                                  Neurology.org for full disclosures.\n                  (ALS-FTD complex).4 Recent studies have suggested\n                  that the most common mutation in familial ALS may               REFERENCES\n                  be a hexanucleotide repeat expansion in C9orf725 with a          1. Brooks BR. El Escorial World Federation of Neurology cri-\n                  frequency of approximately 40%,6,7 and also present                 teria for the diagnosis of ALS. J Neurol Sci 1994;124:96–107.\n                  in up to 13% of apparently sporadic ALS-FTD.                     2. Shefner JM, Tyler HR, Krarup C. Abnormalities in the\n                  The hexanucleotide GGGGCC is normally present in                    sensory action potential in patients with amyotrophic lat-\n                                                                                      eral sclerosis. Muscle Nerve 1991;12:1242.\n                  2–23 copies in the noncoding region of gene C9orf72\n                                                                                   3. Zanette G, Tinazzi M, Polo A, et al. Motor neuron disease\n                  on chromosome 9 and the C9orf72 RNA transcripts are                 with pyramidal tract dysfunction involves the cortical gen-\n                  present in 3 alternatively spliced variants.8 In patients           erators of the early somatosensory evoked potential to tib-\n                  with ALS-FTD, the hexanucleotide GGGGCC is                          ial nerve stimulation. Neurology 1996;47:932–938.\n\n                                                                                  Neurology 81         November 19, 2013                                    e157\n\nª 2013 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f                     4.   Andersen PM, Abrahams S, Borasio GD, et al. EFNS                       carrying a C9orf72 repeat expansion: a population-based\n                          Guidelines on the Clinical Management of Amyotrophic                   cohort study. Lancet Neurol 2012;11:232–240.\n                          Lateral Sclerosis (MALS): revised report of an EFNS task          8.   DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al.\n                          force. Eur J Neurol 2012;19:360–375.                                   Expanded GGGGCC hexanucleotide repeat in noncoding\n                     5.   Renton AE, Majounie E, Waite A, et al. A hexanucleotide                region of C9ORF72 causes chromosome 9p-linked FTD\n                          repeat expansion in C9ORF72 is the cause of chromosome                 and ALS. Neuron 2011;72:245–256.\n                          9p21-linked ALS-FTD. Neuron 2011;72:1–12.                         9.   Simón-Sánchez J, Dopper EGP, Cohn-Hokke PE, et al.\n                     6.   Rutherford NJ, DeJesus-Hernandez M, Baker MC, et al.                   The clinical and pathological phenotype of C9ORF72\n                          C9orf72 hexanucleotide repeat expansions in patients with              hexanucleotide repeat expansions. Brain 2012;135:\n                          ALS from the Coriell cell repository. Neurology 2012;79:               723–735.\n                          482–483.                                                         10.   Abel O, Powell JF, Andersen PM, Al-Chalabi A. ALSoD: a\n                     7.   Byrne S, Elamin M, Bede P, et al. Cognitive and clinical               user-friendly online bioinformatics tool for amyotrophic lat-\n                          characteristics of patients with amyotrophic lateral sclerosis         eral sclerosis genetics. Hum Mutat 2012;33:1345–1351.\n\n\n\n\ne158                Neurology 81     November 19, 2013\n\n  ª 2013 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.\n\f      Clinical Reasoning: Rapidly progressive quadriparesis in a forgetful patient\n             Laura Mantoan Ritter, Jeremy D. Isaacs, Meriel McEntagart, et al.\n                            Neurology 2013;81;e154-e158\n                       DOI 10.1212/01.wnl.0000436063.12890.b2\n\n                    This information is current as of November 18, 2013\n\n Updated Information &              including high resolution figures, can be found at:\n Services                           http://www.neurology.org/content/81/21/e154.full.html\n\n References                         This article cites 10 articles, 3 of which you can access for free at:\n                                    http://www.neurology.org/content/81/21/e154.full.html##ref-list-1\n Subspecialty Collections           This article, along with others on similar topics, appears in the\n                                    following collection(s):\n                                    All Clinical Neurology\n                                    http://www.neurology.org//cgi/collection/all_clinical_neurology\n                                    All Education\n                                    http://www.neurology.org//cgi/collection/all_education\n                                    Amyotrophic lateral sclerosis\n                                    http://www.neurology.org//cgi/collection/amyotrophic_lateral_sclerosi\n                                    s_\n                                    Frontotemporal dementia\n                                    http://www.neurology.org//cgi/collection/frontotemporal_dementia\n Permissions & Licensing            Information about reproducing this article in parts (figures,tables) or in\n                                    its entirety can be found online at:\n                                    http://www.neurology.org/misc/about.xhtml#permissions\n Reprints                           Information about ordering reprints can be found online:\n                                    http://www.neurology.org/misc/addir.xhtml#reprintsus\n\n\n\n\nNeurology ® is the official journal of the American Academy of Neurology. Published continuously since\n1951, it is now a weekly with 48 issues per year. Copyright © 2013 American Academy of Neurology. All\nrights reserved. Print ISSN: 0028-3878. Online ISSN: 1526-632X.",
  "wordCount": 3071,
  "indexed": "2025-09-25T22:54:58.516Z",
  "method": "direct"
}
